Modulation in the expression of type 1 (CR1/CD35) and type 3 (CR3/CD11b) complement receptors on leukocytes from patients with Visceral leishmaniasis
- 1 November 2020
- journal article
- research article
- Published by Elsevier in Experimental Parasitology
- Vol. 218, 107970
Abstract
No abstract availableKeywords
Funding Information
- Fundação Cearense de Apoio ao Desenvolvimento Científico e Tecnológico
This publication has 16 references indexed in Scilit:
- Heterogeneity of peripheral blood monocytes, endothelial dysfunction and subclinical atherosclerosis in patients with systemic lupus erythematosusLupus, 2015
- Leishmania cell wall as a potent target for antiparasitic drugs. A focus on the glycoconjugatesOrganic & Biomolecular Chemistry, 2015
- LeishmaniasisJournal of Infection, 2014
- Immunoregulation in human American leishmaniasis: balancing pathology and protectionParasite Immunology, 2014
- Impact of Leishmania metalloprotease GP63 on macrophage signalingFrontiers in Cellular and Infection Microbiology, 2012
- Complement Receptor 1: Disease associations and therapeutic implicationsMolecular Immunology, 2009
- Monocyte-Mediated Defense Against Microbial PathogensAnnual Review of Immunology, 2008
- Immune Response in Human Visceral Leishmaniasis: Analysis of the Correlation Between Innate Immunity Cytokine Profile and Disease OutcomeScandinavian Journal of Immunology, 2005
- Role of macrophage complement and lectin-like receptors in binding Leishmania parasites to host macrophagesImmunology Letters, 1985
- The Characterization, Origin, and Kinetics of Skin Macrophages During InflammationJournal of Investigative Dermatology, 1985